Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF

European Journal of Preventive Cardiology

11 May 2022
Organised by: Logo
ESC Journals

Abstract

AbstractFunding Acknowledgements

Type of funding sources: None.

Background

Prognostic stratification of acute myocarditis (AM) presenting with normal left ventricular ejection fraction (LVEF) relies mostly on late gadolinium enhancement (LGE) characterization (1).

Purpose

Left ventricular peak global longitudinal strain (LV-GLS) measured by feature tracking analysis might improve prognostication of AM presenting with normal LVEF (2,3).

Methods

Data of patients undergoing cardiac magnetic resonance (CMR) for clinically suspected AM in seven European Centres (2013-2020) were retrospectively analysed. Patients with AM confirmed by CMR and LVEF ≥50% were included. LGE was visually characterized: localized vs. diffuse, subepicardial vs midwall. LV-GLS was measured by dedicated software. The primary outcome was the first occurrence of an adverse cardiovascular event (ACE) including cardiac death, life-threatening arrhythmias, development of heart failure or of LVEF <50%.

Results

Of 389 screened patients, 256 (66%) fulfilled inclusion criteria: median age 36 years, 71% males, median LVEF 60%, median LV-GLS -17.3%. CMR was performed at 4 [2-12] days from hospitalization. At 27 months, 24 (9%) patients experienced ≥1 ACE (71% developed LVEF <50%). Compared to the others, patients experiencing ACEs had lower median LV-GLS values (-13.9% vs -17.5%, p=0.001). At Kaplan-Meier analysis, impaired LV-GLS (both considered as >-20% or quartiles), diffuse and midwall LGE were associated with ACEs (Figure 1). Patients with LV-GLS ≤-20% did not experience ACEs. LV-GLS remained associated with ACEs after adjustment for diffuse and midwall LGE.

Conclusions

In AM presenting with LVEF ≥50%, LV-GLS provides independent prognostic value over LGE characterization, improving risk stratification and representing a rationale for further studies of therapy in this cohort (Figure 2).

Figure 1

Figure 2

Contributors

A Porcari
A Porcari

Author

Royal Free London NHS Foundation Trust London , United Kingdom of Great Britain & Northern Ireland

M Merlo
M Merlo

Author

United Hospitals of Trieste University Hospital Trieste , Italy

G Gagno
G Gagno

Author

University of Trieste Trieste , Italy

C Baggio
C Baggio

Author

University of Trieste Trieste , Italy

A Raafs
A Raafs

Author

A Andreis
A Andreis

Author

Hospital Citta Della Salute e della Scienza di Torino Turin , Italy

D Bromage
D Bromage

Author

King's College London London , United Kingdom of Great Britain & Northern Ireland

A Cannata'
A Cannata'

Author

King's College London London , United Kingdom of Great Britain & Northern Ireland

M Imazio
M Imazio

Author

University Hospital Santa Maria della Misericordia Udine , Italy

M Perazzolo Marra
M Perazzolo Marra

Author

University of Padua Padova , Italy

S Heymans
S Heymans

Author

Cardiovascular Research Institute Maastricht (CARIM) Maastricht , Netherlands (The)